Tekmira Pharmaceuticals (TKMR)

Add to Watchlists
Create an Alert
13.05 -0.93  -6.65% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
TKMR Price Chart
View All Events

TKMR Events

Date Type Description
Mar 06 Misc Tekmira Pharmaceuticals Corporation Q4 2013 Earning Conference Call
Mar 06 Earnings Tekmira Pharmaceuticals Corporation Q4 2013 Earning Result. Estimate: -0.02.
Nov 13 Misc Tekmira and Webcast Advisory: Corporate Update and Third Quarter Financial Conference Call
Nov 13 Earnings Tekmira and Webcast Advisory: Corporate Update and Third Quarter Financial Results. Estimate: -0.03.
Aug 12 Misc Tekmira Conference Call and Webcast Advisory: Corporate Update and Second Quarter Financial Results
Aug 12 Earnings 2013 Second Quarter Financial Results. Estimate: -0.24.
May 14 Earnings Tekmira Provides Corporate Update and Announces First Quarter Results. Estimate: -0.14.
May 14 Misc Tekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results
View All Performance Charts

TKMR Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Tekmira Pharmaceuticals is up 184.3% over the last year vs S&P 500 Total Return up 23.54%, Alnylam Pharmaceuticals up 141.1%, and Isis Pharmaceuticals up 77.32%.

Get Quote for
Advertisement

Portfolio Strategies Featuring TKMR

Did Tekmira Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

TKMR Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: Canada
  • Headquarters State/Province: British Columbia
  • Incorporation Country: Canada
  • Incorporation State/Province: N/A
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A

Tekmira Pharmaceuticals Corporation develops ribonucleic acid interference therapeutic product candidates as well as provides its lipid nanoparticle delivery technology to pharmaceutical partners in the Canada.

Recent Quotes

Symbol Price Chg Chg % Market Cap
TKMR 13.05 -0.93 -6.65% 286.39M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.